Research Article
Platelet-Rich Plasma in the Treatment of Subcutaneous Venous Access Device Scars: A Head-to-Head Patient Survey
Table 1
Results of the primary endpoints (arm pain, decreased mobility, and difficulty in sleeping) for the control group and the PRP (Arthrex ACP) group.
| | | Arm pain | Decreased mobility | Difficulty in sleeping | | | Control | % | ACP | % | Control | % | ACP | % | Control | % | ACP | % |
| | Never | 68 | 69.4 | 16 | 84.2 | 67 | 68.4 | 16 | 84.2 | 68 | 70.1 | 18 | 90 | | Rarely | 22 | 22.4 | 3 | 15.8 | 24 | 24.5 | 3 | 15.8 | 16 | 16.5 | 1 | 5 | | Sometimes | 4 | 4.1 | — | | 2 | 2.0 | — | | 10 | 10.3 | 1 | 5 | | Most of the time | 3 | 3.1 | — | | 4 | 4.1 | — | | 3 | 3.1 | — | | | Always | 1 | 1.0 | — | | 1 | 1.0 | — | | — | | — | |
| | Total | 98 | | 19 | | 98 | | 19 | | 97 | | 20 | | | 0.668 | 0.655 | 0.56 |
|
|
